Vulnerability in Arm Cortex-78c

CVE-2024-5660

Use of Hardware Page Aggregation (HPA) and Stage-1 and/or Stage-2 translation on Cortex-A77, Cortex-A78, Cortex-A78C, Cortex-A78AE, Cortex-A710, Cortex-X1, Cortex-X1C, Cortex-X2, Cortex-X3, Cortex-X4, Cortex-X925, Neoverse V1, Neoverse V2, Neoverse V3, Neoverse V3AE, Neoverse N2 may permit bypass of Stage-2 translation and/or GPT protection.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.006 (44.1th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 44th percentile — 44.1% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2024-5660: held from 0.006 to 0.006.

EPSS over last 30 days · oldest: 0.006 · newest: 0.006 · change: -0.000

Affected products

Weakness classification (CWE)

Public proof-of-concept exploits

References

Frequently asked questions

What is CVE-2024-5660?
CVE-2024-5660 is a critical-severity vulnerability in Arm Cortex-78c, classified under Exposure of Resource to Wrong Sphere. CVSS score: 9.8/10. Published 2024-12-10.
How severe is CVE-2024-5660?
Critical severity. CVSS v3 base score is 9.8 out of 10.
Is CVE-2024-5660 known to be exploited?
1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.